{"id":{"repo_id":"usf","oai_identifier":"oai:digitalcommons.usf.edu:etd-12081"},"canonical_url":"https://search.ndltd.org/etd/usf/oai:digitalcommons.usf.edu:etd-12081","repository":{"repo_id":"usf","name":"University of South Florida","base_url":"https://digitalcommons.usf.edu/do/oai/"},"display":{"title":"Development of antimicrobial guanidinylate polycarbonates","abstract":"The World Health Organization (WHO) has identified the emergence of antibiotic resistance as one of the top 10 threats to public health. This is exemplified by serious threats such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VREF), and the urgent threat posed by Clostridioides difficile to human health. As part of a multifaceted combat strategy against these pathogenic bacteria, host-defense peptide (HDP)-mimicking polymers have proven to be resourceful and promising. However, a vast majority of antibiotic polymer applications were limited to topical applications due to their potential systematic toxicity. Herein, we report the design and synthesis of a series of novel biodegradable polymers – the lipidated antimicrobial guanidinylate polycarbonates. These novel polymers exhibit potent antimicrobial efficacy against both Gram-negative and Gram-positive bacteria, displaying rapid kinetic killing ability and a diminished propensity for resistance development. The bacterial killing process was found to be due to bacterial membrane disruptions, akin to the action mode of HDPs. Importantly, the optimal polymer showed significant antibacterial activity against C. difficile infection (CDI) in vivo through oral administration. In comparison to vancomycin, the standard CDI treatment, the synthesized polymer exhibits a prolonged therapeutic effect and notably reduces CDI recurrence rate. The convenient synthesis, easy scale-up, low cost, as well biodegradability of this class of polycarbonates, together with their in vitro antimicrobial activity and orally in vivo activity against CDI, suggested the great potential of lipidated guandinylate polycarbonates as a new class of antibacterial biomaterials to treat CDI and combat emerging antibiotic resistance. The length of the lipid tail has been modulated to achieve broad-spectrum activity while minimizing hemolytic effects. Moreover, we explored the synergistic potential of using N-Acetyl cysteine (NAC) in conjunction with lipidated guanidinylate polycarbonates. This combination has exhibited enhanced bacterial clearance and improved treatment efficacy, as well as potentiated the activity of the lipidated guanidinylate polycarbonates against both Gram-positive and Gram-negative bacteria, including resistant strains. The amalgamation of NAC and lipidated guanidinylate polycarbonates has also been proven efficacious in inhibiting biofilm formation. Results suggest the combination treatment of NAC and the lipidated guanidinylate polycarbonates may lead to the development of a novel class of antimicrobial agents.","abstract_html":"The World Health Organization (WHO) has identified the emergence of antibiotic resistance as one of the top 10 threats to public health. This is exemplified by serious threats such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VREF), and the urgent threat posed by Clostridioides difficile to human health. As part of a multifaceted combat strategy against these pathogenic bacteria, host-defense peptide (HDP)-mimicking polymers have proven to be resourceful and promising. However, a vast majority of antibiotic polymer applications were limited to topical applications due to their potential systematic toxicity. Herein, we report the design and synthesis of a series of novel biodegradable polymers – the lipidated antimicrobial guanidinylate polycarbonates. These novel polymers exhibit potent antimicrobial efficacy against both Gram-negative and Gram-positive bacteria, displaying rapid kinetic killing ability and a diminished propensity for resistance development. The bacterial killing process was found to be due to bacterial membrane disruptions, akin to the action mode of HDPs. Importantly, the optimal polymer showed significant antibacterial activity against C. difficile infection (CDI) in vivo through oral administration. In comparison to vancomycin, the standard CDI treatment, the synthesized polymer exhibits a prolonged therapeutic effect and notably reduces CDI recurrence rate. The convenient synthesis, easy scale-up, low cost, as well biodegradability of this class of polycarbonates, together with their in vitro antimicrobial activity and orally in vivo activity against CDI, suggested the great potential of lipidated guandinylate polycarbonates as a new class of antibacterial biomaterials to treat CDI and combat emerging antibiotic resistance. The length of the lipid tail has been modulated to achieve broad-spectrum activity while minimizing hemolytic effects. Moreover, we explored the synergistic potential of using N-Acetyl cysteine (NAC) in conjunction with lipidated guanidinylate polycarbonates. This combination has exhibited enhanced bacterial clearance and improved treatment efficacy, as well as potentiated the activity of the lipidated guanidinylate polycarbonates against both Gram-positive and Gram-negative bacteria, including resistant strains. The amalgamation of NAC and lipidated guanidinylate polycarbonates has also been proven efficacious in inhibiting biofilm formation. Results suggest the combination treatment of NAC and the lipidated guanidinylate polycarbonates may lead to the development of a novel class of antimicrobial agents.","abstract_has_math":false,"creators":["Xue, Menglin"],"institution":"University of South Florida","degree_name":"Doctor of Philosophy (Ph.D.)","degree_level":"Dissertation","degree_discipline":"Chemistry","degree_department":null,"school":null,"contributors":["Jianfeng Cai, Ph.D.","Feng Cheng, Ph.D.","Kirpal Bisht, Ph.D.","Wenqi Liu, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2023,"date_issued":"2023-06-30T07:00:00Z","date_published":"2023-06-30T07:00:00Z","updated_at":"2026-11-19T08:49:56Z","subjects":["antimicrobial resistance","Clostridioides difficile","Guanidium","Amphiphilic polymers","Chemistry"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.usf.edu/etd/10794","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://digitalcommons.usf.edu/etd/10794","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.usf.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.usf.edu%3Aetd-12081","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Jianfeng Cai, Ph.D.","Feng Cheng, Ph.D.","Kirpal Bisht, Ph.D.","Wenqi Liu, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Xue, Menglin"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2023-06-30T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation","Ph.D."]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy (Ph.D.)"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of South Florida"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["antimicrobial resistance","Clostridioides difficile","Guanidium","Amphiphilic polymers","Chemistry"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.usf.edu/etd/10794"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["The World Health Organization (WHO) has identified the emergence of antibiotic resistance as one of the top 10 threats to public health. This is exemplified by serious threats such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VREF), and the urgent threat posed by Clostridioides difficile to human health. As part of a multifaceted combat strategy against these pathogenic bacteria, host-defense peptide (HDP)-mimicking polymers have proven to be resourceful and promising. However, a vast majority of antibiotic polymer applications were limited to topical applications due to their potential systematic toxicity. Herein, we report the design and synthesis of a series of novel biodegradable polymers – the lipidated antimicrobial guanidinylate polycarbonates. These novel polymers exhibit potent antimicrobial efficacy against both Gram-negative and Gram-positive bacteria, displaying rapid kinetic killing ability and a diminished propensity for resistance development. The bacterial killing process was found to be due to bacterial membrane disruptions, akin to the action mode of HDPs. Importantly, the optimal polymer showed significant antibacterial activity against C. difficile infection (CDI) in vivo through oral administration. In comparison to vancomycin, the standard CDI treatment, the synthesized polymer exhibits a prolonged therapeutic effect and notably reduces CDI recurrence rate. The convenient synthesis, easy scale-up, low cost, as well biodegradability of this class of polycarbonates, together with their in vitro antimicrobial activity and orally in vivo activity against CDI, suggested the great potential of lipidated guandinylate polycarbonates as a new class of antibacterial biomaterials to treat CDI and combat emerging antibiotic resistance. The length of the lipid tail has been modulated to achieve broad-spectrum activity while minimizing hemolytic effects. Moreover, we explored the synergistic potential of using N-Acetyl cysteine (NAC) in conjunction with lipidated guanidinylate polycarbonates. This combination has exhibited enhanced bacterial clearance and improved treatment efficacy, as well as potentiated the activity of the lipidated guanidinylate polycarbonates against both Gram-positive and Gram-negative bacteria, including resistant strains. The amalgamation of NAC and lipidated guanidinylate polycarbonates has also been proven efficacious in inhibiting biofilm formation. Results suggest the combination treatment of NAC and the lipidated guanidinylate polycarbonates may lead to the development of a novel class of antimicrobial agents."]},{"key":"dc:title","label":"Title","values":["Development of antimicrobial guanidinylate polycarbonates"]}]}],"canonical_facts":{"dc:contributor":["Jianfeng Cai, Ph.D.","Feng Cheng, Ph.D.","Kirpal Bisht, Ph.D.","Wenqi Liu, Ph.D."],"dc:creator":["Xue, Menglin"],"dc:date":["2023-06-30T07:00:00Z"],"dc:description":["The World Health Organization (WHO) has identified the emergence of antibiotic resistance as one of the top 10 threats to public health. This is exemplified by serious threats such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VREF), and the urgent threat posed by Clostridioides difficile to human health. As part of a multifaceted combat strategy against these pathogenic bacteria, host-defense peptide (HDP)-mimicking polymers have proven to be resourceful and promising. However, a vast majority of antibiotic polymer applications were limited to topical applications due to their potential systematic toxicity. Herein, we report the design and synthesis of a series of novel biodegradable polymers – the lipidated antimicrobial guanidinylate polycarbonates. These novel polymers exhibit potent antimicrobial efficacy against both Gram-negative and Gram-positive bacteria, displaying rapid kinetic killing ability and a diminished propensity for resistance development. The bacterial killing process was found to be due to bacterial membrane disruptions, akin to the action mode of HDPs. Importantly, the optimal polymer showed significant antibacterial activity against C. difficile infection (CDI) in vivo through oral administration. In comparison to vancomycin, the standard CDI treatment, the synthesized polymer exhibits a prolonged therapeutic effect and notably reduces CDI recurrence rate. The convenient synthesis, easy scale-up, low cost, as well biodegradability of this class of polycarbonates, together with their in vitro antimicrobial activity and orally in vivo activity against CDI, suggested the great potential of lipidated guandinylate polycarbonates as a new class of antibacterial biomaterials to treat CDI and combat emerging antibiotic resistance. The length of the lipid tail has been modulated to achieve broad-spectrum activity while minimizing hemolytic effects. Moreover, we explored the synergistic potential of using N-Acetyl cysteine (NAC) in conjunction with lipidated guanidinylate polycarbonates. This combination has exhibited enhanced bacterial clearance and improved treatment efficacy, as well as potentiated the activity of the lipidated guanidinylate polycarbonates against both Gram-positive and Gram-negative bacteria, including resistant strains. The amalgamation of NAC and lipidated guanidinylate polycarbonates has also been proven efficacious in inhibiting biofilm formation. Results suggest the combination treatment of NAC and the lipidated guanidinylate polycarbonates may lead to the development of a novel class of antimicrobial agents."],"dc:identifier":["https://digitalcommons.usf.edu/etd/10794"],"dc:subject":["antimicrobial resistance","Clostridioides difficile","Guanidium","Amphiphilic polymers","Chemistry"],"dc:title":["Development of antimicrobial guanidinylate polycarbonates"],"thesis:degree_discipline":["Chemistry"],"thesis:degree_level":["Dissertation","Ph.D."],"thesis:degree_name":["Doctor of Philosophy (Ph.D.)"],"thesis:institution_name":["University of South Florida"]},"updated_at":"2026-11-19T08:49:56Z"}